Exercice de remise en forme
Consulter notre page d’exercice!
http://www.elisebernier.ca/fr/clinique/exercice-de-remise-en-forme.html
Toute l’équipe du Centre de médecine et chirurgie esthétique Dre Élise Bernier est fière de souligner l’obtention par Dre Bernier du diplôme du conseil de certification de l’American Board of Phlebology (ABPh Board certified phlebologist).
Toute l’équipe du Centre de médecine et chirurgie esthétique Dre Élise Bernier est fière de souligner aujourd’hui les 30 ans de carrière en médecine du Dre Élise Bernier. Dre Élise Bernier ayant obtenu son permis de médecine le 16 juin 1980 suite à des études à l’Université de Sherbrooke, elle a ensuite suivi de nombreuses formations en médecine et en chirurgie esthétique. Depuis plusieurs années, elle pratique activement la chirurgie des seins, l’abdominoplastie, la liposculpture, la greffe des cheveux, les traitements de rajeunissement tels Botox Cosmétique, implants injectables, laser de rajeunissement, traitement des varices. Vous pouvez consulter le www.elisebernier.ca pour de plus ample renseignement. Centre de médecine et chirurgie esthétique Dre Élise Bernier, 80 De Vimy Nord, Sherbrooke, Qc 819 822-2555 1800 820 6222, 828 av Querbes, Outremont, QC, Montréal, (514) 278- 2282
«C’est vrai que les femmes s’intéressent beaucoup aux détails et qu’elles se concentrent souvent sur de petites choses que personne ne voit», reconnaît Élise Bernier, une omnipraticienne qui travaille dans le domaine de la médecine esthétique et plastique depuis plus de 20 ans.
http://www.ellequebec.com/accueil/amour/la-beaute-feminine-vue-par-les-hommes/a/31336/3
Le volume lift, ou lift liquide du visage s’effectue avec l »injection de plusieurs seringues d’acide hyaluronique aux endroits stratégiques du visage. Les études permettent de constater un rajeunissement de 6 à 9 ans après seulement 2 à 4 semaines. On note également une durabilité supérieure de la correction lorsque des volumes important sont utilisés.
Effect of Multisyringe Hyaluronic Acid Facial Rejuvenation on Perceived Age.
Taub AF, Sarnoff D, Gold M, Jacob C.
Dermatol Surg. 2010 Jan 19. [Epub ahead of print]
Advanced Dermatology, SKINQRI, LLC, Skinfo, LLC, Lincolnshire, Illinois.
Abstract
BACKGROUND The objective of aesthetic treatments is to create a more youthful appearance. Most injectable fillers are indicated for the reduction of nasolabial folds, but the current aesthetic movement is toward volume replacement in multiple areas, known as global fillers or liquid face-lift. OBJECTIVES To quantify the degree of perceived age reduction from multisyringe hyaluronic acid treatment. MATERIALS AND METHODS Ten women were treated with 6 to 8 mL of hyaluronic acid. Exclusion criteria were no laser for 6 months and no hyaluronic acid fillers for 6 months or semipermanent fillers for 1 year. High-resolution photographs were taken in identical lighting and position before and 2 and 4 weeks after treatment. Three blinded dermatologists rated patients’ ages before and after from photographs. RESULTS The dermatologists reported an average of 6.1 to 7.3 years of reduction in apparent age at 2 and 4 weeks, respectively. The patients perceived a decrease in apparent age of 7.8 and 9 years. CONCLUSION Multisyringe injection of hyaluronic acid filler into the aging face results in a reduction of apparent age from 6.1 to 9 years after 2 to 4 weeks. Full-face correction with hyaluronic acid is an important procedure in the armamentarium of anti-aging techniques. Statistical analysis support and the syringes of Restylane and Perlane were provided by Medicis. Drs. Taub, Gold, and Jacob are consultants to Medicis. Drs. Taub and Jacob are consultants to Allergan.
GUEX J. J. ; HAMEL-DESNOS C. (1) ; GILLET J. L. ; CHLEIR F. ; PERRIN M. ;
(1) Centre Hospitalier Privé Saint Martin, 18, rue des Roquemonts, 14000 Caen, FRANCE
Résumé
Le traitement des varices des membres inférieurs a été profondément modifié par l’apparition de la sclérothérapie écho-guidée à la mousse. Cette technique allie les avantages de l’écho-Doppler pulsé couleur et l’efficacité de la mousse sclérosante : – évaluation ultrasonore préalable nécessaire au diagnostic précis de la maladie, – guidage des ponctions et des injections, – vérification du remplissage des segments cibles, – contrôle des résultats thérapeutiques, -recherche et surveillance des effets secondaires éventuels, -régularité et homogénéité de l’attaque de la paroi veineuse sur de longs segments veineux, -réduction des quantités de sclérosant, – obtention d’un veino-spasme, – efficacité immédiate avec bonne tenue au moins à moyen terme. Efficace et sûre lorsqu’elle est pratiquée par des médecins compétents et entraînés, la méthode permet la prise en charge simple, peu vulnérante et économique de la maladie veineuse chronique superficielle dont on sait qu’il s’agit d’une affection très fréquente, invalidante et coûteuse pour la société. Les résultats très satisfaisants observés à moyen terme nous laissent à penser que la technique va s’imposer largement et perdurer. La stratégie thérapeutique des varices s’en trouve fortement modifiée pour le plus grand bien des patients.
Revue
Phlébologie ISSN 0031-8280 CODEN PHLBA2
2008, vol. 61, no3, pp. 261-270 [10 page(s) (article)] (40 ref.)
Ed. phlébologiques françaises, Paris, FRANCE (1958) (Revue)
Pour obtenir l’article complet:
Zakia Rahman, MD 1, Heather MacFalls, MS 2, Kerrie Jiang, MSN, NP 2, Kin F. Chan, PhD 2, Kristen Kelly, MD 3, Joshua Tournas, MD 3, Oliver F. Stumpp, PhD 2, Vikramaditya Bedi, MS 2, Christopher Zachary, MD 3
Lasers in surgery and medicine 41:78-86
| Abstract |
| Background and Objective |
| Due to the significant risk profile associated with traditional ablative resurfacing, a safer and less invasive treatment approach known as fractional deep dermal ablation (FDDATM) was recently developed. We report the results of the first clinical investigation of this modality for treatment of photodamaged skin. |
| Twenty-four subjects received treatments on the inner forearm with a prototype fractional CO2 laser device (Reliant Technologies Inc., Mountain View, CA) at settings of 5-40 mJ/MTZ and 400 MTZ/cm2. Clinical and histological effects were assessed by study investigators 1 week, 1 month, and 3 months following treatment. Thirty subjects were then enrolled in a multi-center study for treatment of photodamage using the same device. Subjects received 1-2 treatments on the face and neck, with energies ranging from 10 to 40 mJ/MTZ and densities ranging from 400 to 1,200 MTZ/cm2. Study investigators assessed severity of post-treatment responses during follow-up visits 48 hours, 1 week, 1 month, and 3 months following treatment. Using a standard quartile improvement scale (0-4), subjects and investigators assessed improvement in rhytides, pigmentation, texture, laxity and overall appearance 1 and 3 months post-treatment. |
| Results |
| Clinical and histologic results demonstrated that fractional delivery of a 10,600 nm CO2 laser source offers an improved safety profile with respect to traditional ablative resurfacing, while still effectively resurfacing epidermal and dermal tissue. Forearm and facial treatments were well-tolerated with no serious adverse events observed. Eighty-three percent of subjects exhibited moderate or better overall improvement (50-100%), according to study investigator quartile scoring. |
| Conclusions |
| FDDATM treatment is a safe and promising new approach for resurfacing of epidermal and deep dermal tissue targets.
Lasers Surg. Med. 41:78-86, 2009. © 2009 Wiley-Liss, Inc. http://www3.interscience.wiley.com/journal/122208683/abstract
|
May/June 2009: Dr. McCafferty’s Research Published in Aesthetic Surgery Journal
Background
Plastic surgeons and manufacturers of breast implants have been examining the complication and reoperation rates of primary breast augmentations for more than 18 years. The seemingly high rates reported by the manufacturers to the United States Food and Drug Administration (FDA) were the impetus for this multicenter study.
Objective
This paper reports on data pooled from three plastic surgery practices that were geographically distributed across the United States and examines the reoperation rate, time to reoperation, the reason for reoperation, and specific complications in 177 consecutive primary breast augmentation patients. These data are statistically compared to the manufacturers’ 2005 and 2008 FDA data. In addition, the significance of selected variables from our data are examined as predictors for reoperation.
Methods
Data were retrospectively collected from 177 consecutive primary breast augmentations performed between 2001 and 2004 from three surgical practices. Direct physician-to-patient follow-up periods ranged from 12 to 58 months, with 100% of patients having at least one year of follow-up. Each practice extracted chart data on variables and complications, including reoperations. These data were independently collated and sent to an independent biostatistician for analysis.
Results
Our three year Kaplan–Meier (KM) reoperation rate (8%) and capsular contracture rate (2%) were both lower than the manufacturers’ KM 3-year rates for reoperation (13%-21%) and capsular contracture (8.2%-9%). Logistic regression identified only simultaneous mastopexy and preexisting ptosis as predictors of reoperation.
http://www.aestheticsurgeryjournal.org/article/S1090-820X(09)00095-8/abstract
Volume 29, Issue 3, Pages 209-212 (May 2009) Aesthetic surgery journal
Thrombophlebitis of the thoracoepigastric system of veins is a benign disease and, despite its localized involvement and presentation, the condition is known as Mondor disease (MD). A transverse incision made on the thoracoabdominal wall divides the axially arranged superficial veins at a right angle and the presence of unidirectional valves prevents retrograde blood flow, leading to stasis and thrombus formation. The incidence of MD in oncologic breast cases and aesthetic mammaplasties is reported to be 0.95% and 1.07%, respectively. Siliconeadenitis of axillary nodes, on the other hand, is uncommon and has only been reported occasionally. Extensive MD of the left axilla and inner arm is presented following excision of axillary nodes secondary to siliconeadenitis after cohesive gel silicone breast implant rupture.
http://www.aestheticsurgeryjournal.org/article/S1090-820X(09)00104-6/abstract
According to the author, autologous fat transplantation is an ideal technique to correct facial atrophy, providing a stable and potentially long lasting alternative to « off the shelf » fillers. Structural augmentation with fat involves multilayer blunt fat infiltration designed around concepts of volume expansion and resultant tissue shifting. The author has found that retention varies in different parts of the face and fat seems to « take » best in areas in which fat atrophy is the problem, such as in the cheek, periorbital area, and mandible. When fat is being used to replace bony remodeling or mucosal atrophy (both occur in the perioral area), retention can be unpredictable.
Lisa M Donofrio
http://www.biomedsearch.com/nih/Techniques-in-facial-fat-grafting/19083599.html